BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36760145)

  • 1. [Not Available].
    Rønborg S; Høst N; Bieliauskas G; Schrøder J
    Ugeskr Laeger; 2023 Jan; 185(3):. PubMed ID: 36760145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aorto-right ventricular fistula following transcatheter aortic valve implantation using a 29 mm SAPIEN XT valve.
    Hagiwara K; Saito N; Yamazaki K; Kimura T
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28389467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological Factors Associated with Left Ventricular Perforation in Transcatheter Aortic Valve Implantation by Transfemoral Approach.
    Owais T; El Garhy M; Fuchs J; Disha K; Elkaffas S; Breuer M; Lauer B; Kuntze T
    J Heart Valve Dis; 2017 Jul; 26(4):430-436. PubMed ID: 29302942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
    Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Intima-Media Thickness of the Ascending Aorta May Predict Neurological Complications Associated with TAVI.
    Bayar N; Erkal Z; Köklü E; Güven R; Arslan Ş
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105665. PubMed ID: 33631476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional printing for assessment of paravalvular leak in transcatheter aortic valve implantation.
    Thorburn C; Abdel-Razek O; Fagan S; Pearce N; Furey M; Harris S; Bartellas M; Adams C
    J Cardiothorac Surg; 2020 Aug; 15(1):211. PubMed ID: 32758268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Repeated Heart Failure after Transcatheter Aortic Valve Implantation Using Self-expandable Bioprosthetic Valve:Report of a Case].
    Nogami E; Yunoki J; Takeuchi Y; Koga Y; Amamoto S; Takahashi B; Uchino M; Yoshitake S; Itoh M; Koga S; Tanaka A; Kamohara K
    Kyobu Geka; 2021 Sep; 74(9):687-691. PubMed ID: 34446623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Prosthetic Aortic Valve during TAVI Procedure: Endovascular Treatment in Emergent Setting.
    Carli AG; Perini P; Vignali L; Bianchini Massoni C; Fanelli M; Freyrie A
    Ann Vasc Surg; 2021 May; 73():585-588. PubMed ID: 33556523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implantation Karlsruhe (TAVIK) registry.
    Conzelmann LO; Würth A; Schymik G; Schröfel H; Anusic T; Temme S; Tzamalis P; Gerhardus J; Mukherjee C; Gonska BD; Schmitt C; Mehlhorn U
    Eur J Cardiothorac Surg; 2018 Oct; 54(4):752-761. PubMed ID: 29617804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of patients requiring extracorporeal membrane oxygenation in transcatheter aortic valve implantation: a clinical case series.
    Higuchi R; Tobaru T; Hagiya K; Saji M; Takamisawa I; Shimizu J; Iguchi N; Takanashi S; Takayama M; Isobe M
    Heart Vessels; 2018 Nov; 33(11):1343-1349. PubMed ID: 29721672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation: Influence of Pressure Overload on the Evaluation of Lesions Severity.
    Pesarini G; Scarsini R; Zivelonghi C; Piccoli A; Gambaro A; Gottin L; Rossi A; Ferrero V; Vassanelli C; Ribichini F
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Loyalka P; Nascimbene A; Schechter M; Petrovic M; Sundara Raman A; Gregoric ID; Kar B
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1280-1285. PubMed ID: 27696659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late surgical explantation and aortic valve replacement after transcatheter aortic valve implantation.
    Wang LW; Granger EK; McCourt JA; Pye R; Kaplan JM; Muller DW
    Ann Thorac Surg; 2015 Apr; 99(4):1434-6. PubMed ID: 25841830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
    Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Diastolic Flow Reversal Patterns on Clinical Outcomes Following Transcatheter Aortic Valve Implantation - An Intraprocedural Echocardiography Study.
    Ota M; Izumo M; Mochizuki Y; Nishikawa H; Sato Y; Watanabe M; Kaihara T; Okuyama K; Kamijima R; Tanabe Y; Harada T; Shinke T; Akashi YJ
    Circ J; 2021 Jun; 85(7):1068-1075. PubMed ID: 33762527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valve-in-valve transcatheter aortic valve implantation after failed surgically implanted aortic bioprosthesis versus native transcatheter aortic valve implantation for aortic stenosis: Data from a nationwide analysis.
    Deharo P; Bisson A; Herbert J; Lacour T; Saint Etienne C; Jaussaud N; Theron A; Collart F; Bourguignon T; Cuisset T; Fauchier L
    Arch Cardiovasc Dis; 2021 Jan; 114(1):41-50. PubMed ID: 32532695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closure of a high ventricular septal defect after transcatheter aortic valve implantation with an atrial septal occluder-hybrid treatment for a rare complication.
    Hamm K; Reents W; Kerber S; Diegeler A
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):600-602. PubMed ID: 27655741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of aortic stiffness by cardiovascular magnetic resonance following the treatment of severe aortic stenosis by TAVI and surgical AVR.
    Musa TA; Uddin A; Fairbairn TA; Dobson LE; Sourbron SP; Steadman CD; Motwani M; Kidambi A; Ripley DP; Swoboda PP; McDiarmid AK; Erhayiem B; Oliver JJ; Blackman DJ; Plein S; McCann GP; Greenwood JP
    J Cardiovasc Magn Reson; 2016 Jun; 18(1):37. PubMed ID: 27287000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of CT signs and measurements as a predictor of pulmonary hypertension and mortality in symptomatic severe aortic valve stenosis.
    Eberhard M; Mastalerz M; Pavicevic J; Frauenfelder T; Nietlispach F; Maisano F; Tanner FC; Nguyen-Kim TDL
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1637-1651. PubMed ID: 28550588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redo procedures for degenerated stentless aortic xenografts and the role of valve-in-valve transcatheter techniques.
    Grubitzsch H; Zobel S; Christ T; Holinski S; Stangl K; Treskatsch S; Falk V; Laule M
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):653-659. PubMed ID: 28062549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.